Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group

Am J Clin Oncol. 1996 Apr;19(2):114-20. doi: 10.1097/00000421-199604000-00005.

Abstract

We investigated the possible influence of race on the survival of patients with malignant gliomas enrolled in three consecutive trials of the Radiation Therapy Oncology Group (RTOG) retrospectively using the group's statistical database. There were no statistical differences between the survival rates for black patients with glioblastoma multiforme (GBM) and those for the white patients. The limited influence of therapy on this disease may be responsible in part for this result.

MeSH terms

  • Adult
  • Black People*
  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / radiotherapy*
  • Brain Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Glioblastoma / drug therapy
  • Glioblastoma / radiotherapy*
  • Glioblastoma / surgery
  • Humans
  • Information Systems
  • Karnofsky Performance Status
  • Male
  • Middle Aged
  • Multicenter Studies as Topic* / statistics & numerical data
  • Prognosis
  • Proportional Hazards Models
  • Randomized Controlled Trials as Topic* / statistics & numerical data
  • Retrospective Studies
  • Survival Rate
  • Treatment Outcome
  • White People*